OTC
0.00USD
0.00 (0.00%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.8K
P/E
—
EPS
—
Beta
-0.69
52W range
0.0001-0.0002
Day range
0.00–0.00
Open
0.00
Prev close
0.00
Volume
10K
Avg volume
98
Dividend
0.00
IPO
2004-03-29
https://www.newsfilecorp.com/release/301419/ROSEN-A-LONGSTANDING-FIRM-Encourages-Helen-of-Troy-Limited-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-HELE · 6/14/2026-1.00
https://www.newsfilecorp.com/release/301338/ROSEN-A-LEADING-LAW-FIRM-Encourages-FLOW-Cryptocurrency-Investors-to-Inquire-About-Securities-Class-Action-Investigation · 6/13/2026-0.80
https://www.newsfilecorp.com/release/265168/Genix-Pharmaceuticals-Closes-Private-Placement · 9/4/2025+0.40
Genex Pharmaceutical, Inc., operating within the People's Republic of China, specializes in the manufacturing and supply of its Reconstituted Bone Xenograft (RBX). This medical device is specifically designed to accelerate the healing process of bones. The company's products are distributed to an extensive network, reaching around 500 hospitals and numerous other customers in the medical device sector. Genex Pharmaceutical maintains its corporate headquarters in Tianjin City, China.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
